Preliminary results from a phase I/II study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors Meeting Abstract
| Authors: | Sharma, M. R.; Carvajal, R. D.; Hanna, G. J.; Kang, Y. K.; Lee, J.; Lee, K. W.; Li, B. T.; Moore, K. N.; Pegram, M.; Rasco, D.; Spira, A.; Wang, D.; Weinberg, B. A.; Alonso, M.; Fang, L.; Husain, A.; Kowanetz, M.; Perez, E. A.; Dumbrava, E. I. |
| Abstract Title: | Preliminary results from a phase I/II study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors |
| Meeting Title: | ESMO Immuno-Oncology Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2021 Dec 8-11 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-12-01 |
| Start Page: | S1453 |
| End Page: | S1454 |
| Language: | English |
| ACCESSION: | WOS:000731051400167 |
| DOI: | 10.1016/j.annonc.2021.10.183 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 164P -- Source: Wos |
